SG

Shetti Gomtaeshappa Shanthinath

Active Director Director DIN 09339683
DIN 09339683 First appointment Sep 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Shetti Gomtaeshappa Shanthinath

Data last updated:

Shetti Gomtaeshappa Shanthinath is a Director at Respishield Lifesciences Private Limited (since 2021). The company operates in Chemicals.

DIN 09339683
Primary Designation Director
Industry Chemicals
First Appointment 29 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Sep 20212021Active

Board colleagues of Shetti Gomtaeshappa Shanthinath

NameDINCompanyDesignation
Sheety Sharath09339652Respishield Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Respishield Lifesciences Private Limited
Premium access

Shareholding and investment profile for Shetti Gomtaeshappa Shanthinath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shetti Gomtaeshappa Shanthinath

Shetti Gomtaeshappa Shanthinath currently holds 1 directorship: Respishield Lifesciences Private Limited (Director, since 29 Sep 2021).

Shetti Gomtaeshappa Shanthinath was first appointed on 29 Sep 2021 as Director at Respishield Lifesciences Private Limited.

The current boards of Shetti Gomtaeshappa Shanthinath's companies include Sheety Sharath (Respishield Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available